Corrigendum: Late-stage MC38 tumours recapitulate features of human colorectal cancer - implications for appropriate timepoint selection in preclinical studies

Front Immunol. 2024 Jun 11:15:1430460. doi: 10.3389/fimmu.2024.1430460. eCollection 2024.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1152035.].

Keywords: MC38; colorectal cancer; immune exclusion; immunotherapy; syngeneic preclinical models; t cell exhaustion; tumour microenvironment.

Publication types

  • Published Erratum